No Data
No Data
Aditxt's Subsidiary Pearsanta Gets IRB Approval
Express News | Aditxt Inc Withdraws April 14 Release and Says No Replacement Release Will Be Issued
Dr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune
Aditxt's Pearsanta Receives Institutional IRB Approval From WCG Clinical To Initiate Prospective Clinical Study Evaluating Mitomic Endometriosis Test; Plans To Begin Patient Enrollment In May 2025
Express News | Aditxt Subsidiary Pearsanta Receives Irb Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis With Patient Enrollment Planned to Begin in May 2025
Aditxt Regains Nasdaq Compliance With Bid Price